KOD Kodiak Sciences Inc - Common Stock
NASDAQ · Biotechnology · 在 SEC EDGAR 上查看 ↗ 收盘 十月 2, 2026 10-K/10-Q 八月 13, 2026
$94.45
· % 处于52周区间
· 高于低点
· 至高点
$10.9452周低点
$104.0052周高点
市值 (MRQ)
$5.93B
P/E
-21.9
EPS
$-4.32
KOD 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围
价格
$94.45
市值 (MRQ)
$5.93B
P/E
-21.9
EPS
$-4.32
ROE
-202.0%
52周区间
$11–$104
KOD 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图
区间
条形图
柱状图粒度会根据所选周期进行调整 — 将鼠标悬停在图表上可查看柱状图的开盘价/最高价/最低价/收盘价。
关于 Kodiak Sciences Inc - Common Stock 公司概况（来自维基百科）
行业板块Healthcare
行业Biotechnology
员工141
国家US
10年表现 收入、净利润、利润率和每股收益趋势
EPS$-4.322020-12-31 → 2025-12-31
自由现金流$-137M2018-12-31 → 2025-12-31
估值与比率
估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜？
| 指标 | 5年趋势 | KOD | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| P/E | -21.95年均值 ≈-5.5 | ≈-5.5 | · | · | |
| 市净率 (MRQ) | 97.15年均值 ≈4.5 | ≈4.5 | 12.5 | 估值过高 | |
| 股价/自由现金流 (TTM) | -37.15年均值 ≈-8.3 | ≈-8.3 | · | · | |
| 市现率 (TTM) | -37.45年均值 ≈-8.8 | ≈-8.8 | · | · | |
| Price / Tangible Book (市净率（有形资产）) | 37.15年均值 ≈4.5 | ≈4.5 | · | · |
同行中位数按每项指标的标准化基础计算，可能与本股票显示的TTM/MRQ基础不完全匹配。
盈利能力 毛利率、营业利润率和净利率；股本回报率 (ROE)、资产回报率 (ROA)、投入资本回报率 (ROIC)
| 指标 | 5年趋势 | KOD | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| ROA | -66.9%5年均值 ≈-45.0% | ≈-45.0% | -23.8% | 弱 | |
| ROE | -202.0%5年均值 ≈-102.0% | ≈-102.0% | -56.0% | 弱 | |
| ROIC | -149.0%5年均值 ≈-99.2% | ≈-99.2% | -55.8% | 弱 |
财务健康 债务、流动性、偿付能力 — 资产负债表强度
| 指标 | 5年趋势 | KOD | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| 流动比率 (MRQ) | 2.55年均值 ≈7.8 | ≈7.8 | 4.3 | 低流动性 | |
| Quick Ratio (速动比率) | 4.65年均值 ≈7.7 | ≈7.7 | 3.1 | 低流动性 |
成长 营收、每股收益 (EPS) 和净利润增长：同比、3年复合年增长率 (CAGR)、5年复合年增长率 (CAGR)
此比率组尚无数据
基本面数据不足，尚无法计算此比率组。
资本效率 资产周转率、库存周转率、应收账款周转率
此比率组尚无数据
基本面数据不足，尚无法计算此比率组。
价值 · ≈ 5年均值 · 行业中值 · 相对于中值的评判
收益历史 每股收益实际值 vs 预估值，惊喜%，达标率，下次财报日期
平均惊喜
-2.9%
下次报告
十一月 11, 2026
| 期间 | 报告 | EPS Actual | EPS 预期 | 惊喜 |
|---|---|---|---|---|
| 2026年6月30日 | 八月 13, 2026 | $-1.05 | $-0.97 | -8.7% |
| 2026年3月31日 | 五月 20, 2026 | $-0.94 | $-1.02 | 8.1% |
| 2025年12月31日 | $-1.04 | $-1.06 | 2.2% | |
| 2025年9月30日 | $-1.16 | $-1.04 | -11.6% | |
| 2025年6月30日 | $-1.03 | $-1.08 | 4.4% | |
| 2025年3月31日 | $-1.09 | $-0.90 | -20.7% | |
| 2024年12月31日 | $-0.84 | $-0.89 | 6.0% |
完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表
损益表
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $182M | $126M | $206M | $268M | $217M | $107M | $38M | $19M | $22M | |
| SG&A Expense | $52M | $61M | $71M | $74M | $50M | $29M | $12M | $8M | $3M | |
| Operating Expenses | $234M | $187M | $277M | $341M | $267M | $136M | $49M | $26M | $26M | |
| Operating Income | $-234M | $-187M | $-277M | $-341M | $-267M | $-136M | $-49M | $-26M | $-26M | |
| Interest Expense | $0 | $0 | $13.0K | $18.0K | $47.0K | $25.0K | $8.0K | $6M | $1M | |
| Interest Income | $5M | $11M | $17M | $7M | $298.0K | $3M | $2M | $617.0K | $29.0K | |
| Other Non-op | $-96.0K | $-506.0K | $110.0K | $503.0K | $-190.0K | $-30.0K | $265.0K | $-5M | $-1M | |
| Pretax Income | $-230M | $-176M | $-260M | $-334M | $-267M | $-133M | $-47M | $-41M | $-28M | |
| Income Tax | $52.0K | $20.0K | $33.0K | $33.0K | $74.0K | $14.0K | · | · | · | |
| Net Income | $-230M | $-176M | $-260M | $-334M | $-267M | $-133M | $-47M | $-41M | $-28M | |
| EPS (Basic) | $-4.32 | $-3.35 | $-4.97 | $-6.39 | $-5.16 | $-2.91 | · | · | · | |
| EPS (Diluted) | $-4.32 | $-3.35 | $-4.97 | $-6.39 | $-5.16 | $-2.91 | · | · | · | |
| Shares (Basic) | 53,208,311 | 52,583,148 | 52,414,256 | 52,249,620 | 51,788,918 | 45,741,845 | · | · | · | |
| Shares (Diluted) | 53,208,311 | 52,583,148 | 52,414,256 | 52,249,620 | 51,788,918 | 45,741,845 | · | · | · | |
| EBITDA | $-234M | $-187M | $-277M | $-341M | $-267M | $-136M | $-49M | $-26M | · |
资产负债表
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $210M | $168M | $286M | $190M | $732M | $944M | $212M | $88M | $1M | |
| Short-term Investments | · | · | $0 | $288M | $0 | $25M | $125M | · | · | |
| Prepaid Expense | $5M | $4M | $4M | $7M | $3M | $3M | $3M | $2M | $200.0K | |
| Current Assets | $215M | $172M | $289M | $486M | $735M | $972M | $339M | $90M | $2M | |
| PP&E (Net) | $85M | $102M | $120M | $56M | $41M | $5M | $996.0K | $1M | $2M | |
| PP&E (Gross) | $145M | $143M | $143M | $63M | $44M | $7M | $3M | $3M | $3M | |
| Accum. Depreciation | $59M | $41M | $23M | $7M | $3M | $2M | $2M | $2M | $1M | |
| Other Non-current Assets | $9M | $9M | $9M | $59M | $55M | $10M | $5M | $503.0K | · | |
| Total Assets | $352M | $336M | $479M | $667M | $904M | $1.07B | $359M | $92M | $3M | |
| Accounts Payable | $13M | $4M | $14M | $9M | $12M | $9M | $3M | $1M | $3M | |
| Accrued Liabilities | $21M | $11M | $18M | $33M | $48M | $20M | $9M | $4M | $6M | |
| Current Liabilities | $46M | $26M | $42M | $52M | $65M | $31M | $12M | $5M | $9M | |
| Capital Leases | $47M | $60M | $72M | $78M | $76M | $75M | $2M | · | · | |
| Other Non-current Liabilities | · | · | $0 | $162.0K | $211.0K | $256.0K | $295.0K | $530.0K | $586.0K | |
| Total Liabilities | $194M | $185M | $214M | $230M | $241M | $207M | $14M | $5M | $22M | |
| Common Stock | $6.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $4.0K | $1.0K | |
| Retained Earnings | $-1.56B | $-1.33B | $-1.15B | $-892M | $-558M | $-291M | $-158M | $-111M | $-69M | |
| AOCI | · | · | $0 | $-1M | $0 | $53.0K | $10.0K | · | · | |
| Stockholders' Equity | $157M | $150M | $266M | $436M | $663M | $861M | $345M | $87M | $-69M | |
| Liabilities + Equity | $352M | $336M | $479M | $667M | $904M | $1.07B | $359M | $92M | $3M | |
| Shares Outstanding | 61,758,454 | 52,726,916 | 52,508,602 | 52,333,850 | 51,826,257 | 51,112,302 | 44,413,404 | 36,829,857 | 7,936,434 |
现金流
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $59M | $60M | $89M | $106M | $61M | $31M | $6M | $3M | $275.0K | |
| Deferred Tax | · | $0 | $0 | $0 | $0 | $0 | · | · | · | |
| Operating Cash Flow | $-136M | $-117M | $-154M | $-206M | $-182M | $-83M | $-39M | $-29M | $-18M | |
| CapEx | $506.0K | $375.0K | $41M | $37M | $17M | $4M | $437.0K | $78.0K | $209.0K | |
| Investing Cash Flow | $-506.0K | $-755.0K | $249M | $-337M | $-39M | $105M | $-137M | $-581.0K | $-209.0K | |
| Stock Issued | · | · | · | $0 | $0 | $612M | $298M | $84M | · | |
| Stock Repurchased | · | · | · | · | · | · | · | $0 | $0 | |
| Net Stock Activity | · | · | · | $0 | · | $612M | $298M | $84M | · | |
| Financing Cash Flow | $178M | $501.0K | $31.0K | $2M | $8M | $717M | $300M | $116M | $10M | |
| Taxes Paid | $0 | $0 | $0 | · | · | · | · | · | · | |
| Free Cash Flow | $-137M | $-118M | $-196M | $-243M | $-199M | $-87M | $-40M | $-29M | · | |
| Levered FCF | $-137M | $-118M | $-196M | $-243M | $-199M | $-87M | · | · | · |
盈利能力
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -66.9% | -43.2% | -45.5% | -42.5% | -27.1% | -18.7% | -21.0% | -86.9% | · | |
| ROE | -202.0% | -105.0% | -91.7% | -72.9% | -38.4% | -23.3% | -23.4% | 1184.6% | · | |
| ROIC | -149.0% | -124.3% | -104.3% | -78.3% | -40.3% | -15.8% | · | · | · |
流动性与偿付能力
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.7 | 6.7 | 6.9 | 9.3 | 11.4 | 30.9 | 29.0 | 18.7 | · | |
| Quick Ratio | 4.6 | 6.6 | 6.8 | 9.1 | 11.3 | 30.8 | 28.7 | 18.3 | · | |
| Interest Coverage | · | · | -21332.4 | -18965.5 | -12138.7 | -5440.3 | -6148.8 | -4.8 | · |
每股
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $2.55 | $2.86 | $5.06 | $8.33 | $12.80 | $16.84 | $7.78 | $2.36 | · | |
| Cash Flow / Share | $-2.56 | $-2.23 | $-2.94 | $-3.95 | · | · | · | · | · | |
| Cash / Share | $3.40 | $3.20 | $5.44 | $3.64 | $14.11 | $18.48 | $4.77 | $2.40 | · | |
| EPS (TTM) | $-4.32 | $-3.35 | $-4.97 | $-6.39 | $-5.16 | $-2.91 | · | · | · |
估值 (TTM)
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-230M | $-176M | $-260M | $-334M | $-267M | $-133M | $-47M | $-41M | · | |
| Market Cap | $1.73B | $522M | $160M | $375M | $4.39B | $7.51B | $3.20B | $261M | · | |
| P/E | -6.5 | -3.0 | -0.6 | -1.1 | -16.4 | -50.5 | · | · | · | |
| P/B | 11.0 | 3.5 | 0.6 | 0.9 | 6.6 | 8.7 | 9.3 | 3.0 | · | |
| P / Tangible Book | 11.0 | 3.5 | 0.6 | 0.9 | 6.6 | 8.7 | · | · | · | |
| P / Cash Flow | -12.7 | -4.5 | -1.0 | -1.8 | -24.1 | -90.0 | -81.6 | -9.0 | · | |
| P / FCF | -12.6 | -4.4 | -0.8 | -1.5 | -22.0 | -86.1 | -80.7 | -9.0 | · | |
| Earnings Yield | -15.4% | -33.7% | -163.5% | -89.2% | -6.1% | -2.0% | · | · | · |
损益表
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $56M | $49M | $45M | $50M | $43M | $44M | $32M | $32M | $33M | $30M | $36M | $67M | $57M | $62M | $74M | $76M | |
| SG&A Expense | $11M | $11M | $12M | $12M | $13M | $15M | $14M | $15M | $15M | $16M | $18M | $18M | $18M | $18M | $18M | $20M | |
| Operating Expenses | $67M | $60M | $57M | $62M | $56M | $59M | $46M | $47M | $48M | $46M | $54M | $85M | $75M | $79M | $92M | $96M | |
| Operating Income | $-67M | $-60M | $-57M | $-62M | $-56M | $-59M | $-46M | $-47M | $-48M | $-46M | $-54M | $-85M | $-75M | $-79M | $-92M | $-96M | |
| Interest Expense | · | · | · | · | · | · | $0 | $0 | $0 | $0 | $5.0K | $4.0K | $4.0K | $4.0K | $5.0K | $5.0K | |
| Interest Income | $1M | $2M | $757.0K | $917.0K | $1M | $2M | $2M | $3M | $3M | $3M | $5M | $5M | $4M | $2M | $1M | $76.0K | |
| Other Non-op | $-60.0K | $-22.0K | $-40.0K | $-22.0K | $-44.0K | $10.0K | $-56.0K | $-25.0K | $-88.0K | $-337.0K | $-38.0K | $-35.0K | $222.0K | $-40.0K | $-49.0K | $-13.0K | |
| Net Income | $-66M | $-58M | $-57M | $-61M | $-54M | $-57M | $-44M | $-44M | $-45M | $-43M | $-50M | $-80M | $-71M | $-77M | $-91M | $-96M | |
| EPS (Basic) | $-1.05 | $-0.94 | $-1.04 | $-1.16 | $-1.03 | $-1.09 | $-0.83 | $-0.84 | $-0.86 | $-0.82 | $-0.95 | $-1.53 | $-1.35 | $-1.47 | $-1.74 | $-1.83 | |
| EPS (Diluted) | $-1.05 | $-0.94 | $-1.04 | $-1.16 | $-1.03 | $-1.09 | $-0.83 | $-0.84 | $-0.86 | $-0.82 | $-0.95 | $-1.53 | $-1.35 | $-1.47 | $-1.74 | $-1.83 | |
| Shares (Basic) | 62,628,596 | 61,859,485 | · | 52,859,308 | 52,779,162 | 52,746,318 | · | 52,616,183 | 52,554,215 | 52,510,460 | 52,455,620 | 52,378,729 | 52,337,603 | 52,288,257 | 52,218,773 | 52,172,918 | |
| Shares (Diluted) | 62,628,596 | 61,859,485 | · | 52,859,308 | 52,779,162 | 52,746,318 | · | 52,616,183 | 52,554,215 | 52,510,460 | 52,455,620 | 52,378,729 | 52,337,603 | 52,288,257 | 52,218,773 | 52,172,918 | |
| EBITDA | $-67M | $-60M | · | $-62M | $-56M | $-59M | · | $-47M | $-48M | $-46M | $-54M | $-85M | $-75M | $-79M | $-92M | $-96M |
资产负债表
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $126M | $170M | $210M | $72M | $104M | $139M | $168M | $198M | $219M | $246M | $346M | $379M | $317M | $178M | $173M | $672M | |
| Short-term Investments | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $105M | $359M | $425M | · | |
| Prepaid Expense | $5M | $6M | $5M | $4M | $4M | $4M | $4M | $5M | $5M | $6M | $5M | $8M | $10M | $7M | $6M | $10M | |
| Current Assets | $131M | $175M | $215M | $76M | $108M | $143M | $172M | $202M | $225M | $252M | $351M | $387M | $431M | $545M | $604M | $682M | |
| PP&E (Net) | $78M | $82M | $85M | $89M | $93M | $98M | $102M | $107M | $111M | $116M | $125M | $130M | $135M | $56M | $55M | $49M | |
| PP&E (Gross) | · | · | $145M | · | · | · | $143M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $59M | · | · | · | $41M | · | · | · | · | · | · | · | · | · | |
| Other Non-current Assets | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $56M | $54M | $48M | |
| Total Assets | $257M | $306M | $352M | $218M | $257M | $298M | $336M | $373M | $402M | $435M | $548M | $590M | $640M | $724M | $782M | $850M | |
| Accounts Payable | $13M | $11M | $13M | $10M | $5M | $7M | $4M | $3M | $2M | $2M | $39M | $12M | $6M | $16M | $21M | $13M | |
| Accrued Liabilities | $30M | $27M | $21M | $20M | $15M | $13M | $11M | $11M | $9M | $13M | $23M | $54M | $55M | $41M | $43M | $58M | |
| Current Liabilities | $53M | $50M | $46M | $42M | $31M | $31M | $26M | $24M | $21M | $25M | $71M | $74M | $69M | $66M | $70M | $76M | |
| Capital Leases | $43M | $44M | $47M | $50M | $54M | $57M | $60M | $63M | $66M | $69M | $74M | $77M | $79M | $79M | $81M | $76M | |
| Other Non-current Liabilities | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | $175.0K | $187.0K | $199.0K | |
| Total Liabilities | $196M | $194M | $194M | $194M | $186M | $189M | $185M | $187M | $187M | $194M | $245M | $251M | $248M | $244M | $251M | $253M | |
| Common Stock | $6.0K | $6.0K | $6.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | |
| Retained Earnings | $-1.68B | $-1.62B | $-1.56B | $-1.50B | $-1.44B | $-1.39B | $-1.33B | $-1.28B | $-1.24B | $-1.20B | $-1.09B | $-1.04B | $-963M | $-822M | $-745M | $-654M | |
| AOCI | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $-96.0K | $-3M | $-2M | · | |
| Stockholders' Equity | $61M | $112M | $157M | $24M | $70M | $109M | $150M | $185M | $215M | $241M | $302M | $338M | $393M | $480M | $531M | $597M | |
| Liabilities + Equity | $257M | $306M | $352M | $218M | $257M | $298M | $336M | $373M | $402M | $435M | $548M | $590M | $640M | $724M | $782M | $850M | |
| Shares Outstanding | 62,830,860 | 62,155,685 | 61,758,454 | 52,998,561 | 52,821,689 | 52,751,875 | 52,726,916 | 52,623,087 | 52,614,729 | 52,523,447 | 52,467,291 | 52,453,163 | 52,344,741 | 52,304,154 | 52,024,621 | 51,939,881 |
现金流
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $12M | $12M | $13M | $14M | $16M | $16M | $9M | $15M | $18M | $18M | $14M | $26M | $26M | $26M | $26M | $28M | |
| Operating Cash Flow | $-46M | $-40M | $-39M | $-33M | $-35M | $-29M | $-30M | $-21M | $-26M | $-40M | $-33M | $-42M | $-47M | $-53M | $-55M | $-43M | |
| CapEx | $352.0K | $942.0K | $43.0K | $60.0K | $133.0K | $270.0K | $124.0K | $180.0K | $49.0K | $22.0K | $226.0K | $1M | $12M | $8M | $8M | $17M | |
| Investing Cash Flow | $-352.0K | $-942.0K | $-43.0K | $-60.0K | $-133.0K | $-270.0K | $-124.0K | $-205.0K | $-260.0K | $-166.0K | $-226.0K | $104M | $173M | $59M | $-444M | $-18M | |
| Financing Cash Flow | $3M | $619.0K | $177M | $813.0K | $120.0K | $124.0K | $404.0K | $0 | $59.0K | $38.0K | $-12.0K | $170.0K | $-3.0K | $78.0K | $54.0K | $2M | |
| Free Cash Flow | · | $-41M | · | · | · | $-29M | · | · | · | $-40M | · | · | $-59M | · | · | $-61M |
盈利能力
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -25.6% | -19.3% | · | -20.8% | -16.5% | -15.7% | · | -9.6% | -9.1% | -8.0% | -7.9% | -11.7% | -9.5% | -9.2% | -10.2% | -10.2% | |
| ROE | -99.9% | -52.6% | · | -58.8% | -38.1% | -32.8% | · | -18.0% | -16.3% | -13.6% | -12.8% | -18.4% | -14.3% | -12.8% | -13.8% | -13.5% |
流动性与偿付能力
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.5 | 3.5 | · | 1.8 | 3.5 | 4.6 | · | 8.4 | 10.6 | 10.1 | 5.0 | 5.2 | 6.3 | 8.3 | 8.7 | 8.9 | |
| Quick Ratio | 2.4 | 3.4 | · | 1.7 | 3.4 | 4.5 | · | 8.2 | 10.3 | 9.9 | 4.9 | 5.1 | 6.1 | 8.2 | 8.6 | 8.8 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | · | -10900.0 | -21208.0 | -18653.8 | -19869.5 | -18413.6 | -19153.4 |
每股
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.97 | $1.80 | · | $0.45 | $1.33 | $2.06 | · | $3.52 | $4.08 | $4.59 | $5.76 | $6.45 | $7.50 | $9.17 | $10.21 | $11.50 | |
| Cash Flow / Share | · | $-0.65 | · | · | · | $-0.55 | · | · | · | $-0.75 | · | · | $-0.90 | · | · | · | |
| Cash / Share | $2.00 | $2.73 | · | $1.36 | $1.97 | $2.63 | · | $3.76 | $4.17 | $4.68 | $6.59 | $7.22 | $6.05 | $3.41 | $3.32 | $12.93 | |
| EPS (TTM) | $-4.19 | $-4.17 | · | $-4.11 | $-3.79 | $-3.62 | · | $-3.66 | $-3.77 | $-4.44 | $-5.18 | $-5.70 | $-5.91 | $-6.84 | $-6.67 | $-6.01 |
估值 (TTM)
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-242M | $-231M | · | $-217M | $-200M | $-191M | · | $-192M | $-198M | $-233M | $-271M | $-298M | $-309M | $-357M | $-347M | $-312M | |
| Market Cap | $2.45B | $2.37B | · | $868M | $197M | $148M | · | $137M | $124M | $276M | $94M | $362M | $325M | $405M | $397M | $401M | |
| P/E | -9.3 | -9.1 | · | -4.0 | -1.0 | -0.8 | · | -0.7 | -0.6 | -1.2 | -0.3 | -1.2 | -1.0 | -1.1 | -1.1 | -1.3 | |
| P/B | 40.1 | 21.1 | · | 36.6 | 2.8 | 1.4 | · | 0.7 | 0.6 | 1.1 | 0.3 | 1.1 | 0.8 | 0.8 | 0.7 | 0.7 | |
| P / Tangible Book | 40.1 | 21.1 | · | 36.6 | 2.8 | 1.4 | · | 0.7 | 0.6 | 1.1 | 0.3 | 1.1 | 0.8 | 0.8 | 0.7 | 0.7 | |
| P / Cash Flow | · | -59.2 | · | · | · | -5.1 | · | · | · | -7.0 | · | · | -6.9 | · | · | -9.3 | |
| Earnings Yield | -10.8% | -10.9% | · | -25.1% | -101.6% | -128.8% | · | -140.2% | -160.4% | -84.4% | -287.8% | -82.6% | -95.3% | -88.4% | -87.3% | -77.8% |
最近期在左侧 · 空值显示为 ·
财务报表 损益表、资产负债表、现金流量表 — 年度，近5年
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 净收入 | $-230M | $-176M | $-260M | $-334M | $-267M |
| 稀释后每股收益 (EPS) | $-4.32 | $-3.35 | $-4.97 | $-6.39 | $-5.16 |
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 流动比率 | 4.7 | 6.7 | 6.9 | 9.3 | 11.4 |
| 速动比率 | 4.6 | 6.6 | 6.8 | 9.1 | 11.3 |
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 自由现金流 | $-137M | $-118M | $-196M | $-243M | $-199M |
机构持有人 (13F) 214 家申报者 · $2.3B 总计 · 截至 2026年6月30日
在其季度SEC表格13F中报告持有此股票的机构。仅限多头头寸；单个申报人可能因单独的期权腿而出现两次。 大的抵消性看跌/看涨腿通常反映做市或对冲库存，而非方向性判断。
持有人
214
持有价值
$2.3B
新仓位
34
已退出持仓
22
机构活动 — Q2 2026 与上一季度对比
| 新仓位 | 已退出持仓 | 增加 | 减少 | 净股数变动 |
|---|---|---|---|---|
| 34 (-30 与上一季度对比) | 22 (+4 与上一季度对比) | 90 (+21 与上一季度对比) | 59 (+7 与上一季度对比) | +1.6M |
与Q1 2026对比。 SEC 13F表格的提交截止日期是季度末后45天，外加少量延迟提交的缓冲期——在此窗口期内的季度将被跳过，优先显示最近一个已完整报告的季度对。
| 机构 | 价值 | 股份 | % 已追踪的13F | 类型 |
|---|---|---|---|---|
| BAKER BROS. ADVISORS LP | $776051487 | 19919186 | 34.06% | 股份 |
| BlackRock, Inc. | $161113431 | 4135355 | 7.07% | 股份 |
| STATE STREET CORP | $94260486 | 2419417 | 4.14% | 股份 |
| GOLDMAN SACHS GROUP INC | $90231905 | 2316014 | 3.96% | 股份 |
| VANGUARD CAPITAL MANAGEMENT LLC | $70308463 | 1804632 | 3.09% | 股份 |
| BRAIDWELL LP | $69633909 | 1787318 | 3.06% | 股份 |
| VANGUARD GROUP INC | $64682524 | 2313395 | 2.84% | 股份 |
| RTW INVESTMENTS, LP | $57969909 | 1487934 | 2.54% | 股份 |
| Boxer Capital Management, LLC | $57567296 | 1477600 | 2.53% | 股份 |
| TCG Crossover Management, LLC | $56318161 | 1445538 | 2.47% | 股份 |
| JANUS HENDERSON GROUP PLC | $50539675 | 1325457 | 2.22% | 股份 |
| ICONIQ Capital, LLC | $49345294 | 1266563 | 2.17% | 股份 |
| GEODE CAPITAL MANAGEMENT, LLC | $41420974 | 1062955 | 1.82% | 股份 |
| Ikarian Capital, LLC | $41287080 | 1059730 | 1.81% | 股份 |
| Artisan Partners Limited Partnership | $37714722 | 968037 | 1.66% | 股份 |
| WELLINGTON MANAGEMENT GROUP LLP | $30919164 | 793613 | 1.36% | 股份 |
| Board of Trustees of The Leland Stanford Junior University | $26951242 | 691767 | 1.18% | 股份 |
| SILVERARC CAPITAL MANAGEMENT, LLC | $21282134 | 546256 | 0.93% | 股份 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $20758628 | 532819 | 0.91% | 股份 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $19480000 | 500000 | 0.85% | 股份 |
| Squadron Capital Management LLC | $19480000 | 500000 | 0.85% | 股份 |
| TWO SIGMA INVESTMENTS, LP | $18428119 | 473001 | 0.81% | 股份 |
| MORGAN STANLEY | $16948748 | 435029 | 0.74% | 股份 |
| BANK OF AMERICA CORP /DE/ | $14949303 | 383709 | 0.66% | 股份 |
| BOONE CAPITAL MANAGEMENT LLC | $14727270 | 378010 | 0.65% | 股份 |
| NORTHERN TRUST CORP | $14291579 | 366827 | 0.63% | 股份 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $13949862 | 358056 | 0.61% | 股份 |
| DIMENSIONAL FUND ADVISORS LP | $12174462 | 312595 | 0.53% | 股份 |
| VANGUARD FIDUCIARY TRUST CO | $11375112 | 291969 | 0.50% | 股份 |
| FMR LLC | $10791298 | 276984 | 0.47% | 股份 |
| BOOTHBAY FUND MANAGEMENT, LLC | $10344815 | 265524 | 0.45% | 股份 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $9346504 | 239900 | 0.41% | 买入期权 |
| DIADEMA PARTNERS LP | $8497838 | 218117 | 0.37% | 股份 |
| Ikarian Capital, LLC | $8481592 | 217700 | 0.37% | 买入期权 |
| D. E. Shaw & Co., Inc. | $8232248 | 211300 | 0.36% | 股份 |
| DIADEMA PARTNERS LP | $7663432 | 196700 | 0.34% | 买入期权 |
| TD Asset Management Inc | $7563383 | 194132 | 0.33% | 股份 |
| PFM Health Sciences, LP | $7531552 | 193315 | 0.33% | 股份 |
| UBS Group AG | $7406880 | 190115 | 0.33% | 股份 |
| RENAISSANCE TECHNOLOGIES LLC | $7371232 | 189200 | 0.32% | 股份 |
| ALGERT GLOBAL LLC | $7265105 | 186476 | 0.32% | 股份 |
| Nuveen, LLC | $6807481 | 174730 | 0.30% | 股份 |
| CITADEL ADVISORS LLC | $6137135 | 157524 | 0.27% | 股份 |
| Squarepoint Ops LLC | $5886778 | 151098 | 0.26% | 股份 |
| Ghisallo Capital Management LLC | $5844000 | 150000 | 0.26% | 股份 |
| DIADEMA PARTNERS LP | $5723224 | 146900 | 0.25% | 卖出期权 |
| Bruce & Co., Inc. | $5649200 | 145000 | 0.25% | 股份 |
| FEDERATED HERMES, INC. | $5612772 | 144065 | 0.25% | 股份 |
| PRUDENTIAL FINANCIAL INC | $4694485 | 120495 | 0.21% | 股份 |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $4444907 | 114089 | 0.20% | 股份 |
激进投资者及 5%+ 股东 2 持仓
提交了 SEC Schedule 13D 的投资者 — 持有超过 5% 的受益所有权，意图影响发行人（激进股东持股、董事会活动、并购）。每一行显示该申报人持仓的最新已知状态。
| 申报人 | 已申报 | 持股 | 状态 | 目的 | 申报 |
|---|---|---|---|---|---|
| Baker Bros. Advisors (GP) LLC, Baker Bros. Advisors LP, Felix J. Baker, Julian C. Baker | 2026年9月30日 | 35.00% | 修订 | 被动投资 | SEC |
| Baker Bros. Advisors LP, Baker Bros. Advisors (GP) LLC, Julian C. Baker, Felix J. Baker ×12 申报 | 2025年12月19日 | 32.80% | 修订 | 资本结构 | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
公司内部人士 9 位内幕人士 · 4 位高管 · 6 位董事
| 内部人士 | 角色 | 上次活动 | 持股数量 | 买入 12个月 | 卖出 12个月 | 净额 12个月 |
|---|---|---|---|---|---|---|
| Victor Perlroth | Chairman and CEO | 2026年9月25日 M | 3676062 | 0 | 0 | $0 |
| John A. Borgeson | Chief Financial Officer | 2026年7月15日 A | 211930 | 0 | 6 | $-2220497 |
| Jason Ehrlich | Chief Medical Officer and Chief Development Officer | 2023年6月24日 A | 61924 | 0 | 0 | $0 |
| Hong Liang | SVP, Discovery Medicine | 2020年4月2日 S | 130166 | 0 | 0 | $0 |
| Bassil I Dahiyat | 董事 | 2026年6月30日 A | · | 0 | 0 | $0 |
| Charles A Bancroft | 董事 | 2026年6月30日 A | · | 0 | 0 | $0 |
| Richard S Levy | 董事 | 2026年6月30日 A | 1000 | 0 | 0 | $0 |
| Taiyin Yang | 董事 | 2026年6月30日 A | · | 0 | 0 | $0 |
| Robert Profusek | 董事 | 2026年6月30日 A | · | 0 | 0 | $0 |
来自SEC表格3/4/5申报的内部人士；净额=仅公开市场买卖
ETF持仓 由 29 只交易所交易基金持有
权重仅反映直接股权持仓（N-PORT）；杠杆基金或基于衍生品的基金可能持有未显示的额外掉期敞口。
| 基金 | 权重 | 单位 | 截至 | 来源 |
|---|---|---|---|---|
| BBC · ETFis Series Trust I | 0.82% | 9125 NS | 2026年7月31日 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0.43% | 50808 NS | 2026年7月31日 | N-PORT |
| IBBQ · Invesco Exchange-Traded Fund Trus... | 0.41% | 4423 SH | 2026年10月2日 | 每日 |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0.14% | 38803 SH | 2026年10月2日 | 每日 |
| IBB · iShares Trust | 0.14% | 443467 SH | 2026年9月11日 | 每日 |
| VFMO · VANGUARD WELLINGTON FUND | 0.14% | 70377 SH | 2026年8月19日 | 每日 |
| PWS · Pacer Funds Trust | 0.12% | 694 NS | 2026年7月31日 | N-PORT |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0.09% | 42202 SH | 2026年8月19日 | 每日 |
| IWO · iShares Trust | 0.08% | 369841 SH | 2026年9月11日 | 每日 |
| BBSC · J.P. Morgan Exchange-Traded Fund ... | 0.06% | 10682 NS | 2026年7月31日 | N-PORT |
| RSSL · Global X Funds | 0.05% | 18846 NS | 2026年7月31日 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.05% | 226556 SH | 2026年8月19日 | 每日 |
| IWM · iShares Trust | 0.04% | 1011605 SH | 2026年9月11日 | 每日 |
| VXF · VANGUARD INDEX FUNDS | 0.02% | 475491 SH | 2026年8月19日 | 每日 |
| VHT · VANGUARD WORLD FUND | 0.02% | 93063 SH | 2026年8月19日 | 每日 |
| FHLC · FIDELITY COVINGTON TRUST | 0.02% | 14697 NS | 2026年7月31日 | N-PORT |
| WSML · iShares Trust | 0.01% | 1802 SH | 2026年9月11日 | 每日 |
| DFAS · Dimensional ETF Trust | 0.01% | 23200 NS | 2026年7月31日 | N-PORT |
| DCOR · Dimensional ETF Trust | 0.00% | 3093 NS | 2026年7月31日 | N-PORT |
| DFAU · Dimensional ETF Trust | 0.00% | 8843 NS | 2026年7月31日 | N-PORT |
| IWV · iShares Trust | 0.00% | 14520 SH | 2026年9月10日 | 每日 |
| ITOT · iShares Trust | 0.00% | 61260 SH | 2026年9月11日 | 每日 |
| DFUS · Dimensional ETF Trust | 0.00% | 4260 NS | 2026年7月31日 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 1288755 SH | 2026年8月19日 | 每日 |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 3260 SH | 2026年8月19日 | 每日 |
| DXUV · Dimensional ETF Trust | 0.00% | 4 NS | 2026年7月31日 | N-PORT |
| ISCB · iShares Trust | · | 1789 SH | 2026年9月11日 | 每日 |
| ISCV · iShares Trust | · | 8719 SH | 2026年9月11日 | 每日 |
| SMLF · iShares Trust | · | 15858 SH | 2026年9月11日 | 每日 |
KOD 分析师共识 看涨和看跌分析师观点、12个月价格目标、上涨空间
评级 · 10 位分析师
买入
中位数目标
$116.00
+22.8%
2 20.0%
强烈买入
7 70.0%
买入
1 10.0%
持有
0 0.0%
卖出
0 0.0%
强烈卖出
12个月价格目标
6 位分析师 · 2026-10-03平均目标 $116.67 +23.5%
← 低于所有目标
当前价格 $94.45
最低$96.00
平均值$116.67
最高$145.00
同行比较（GICS 子行业） 关键指标与行业同行对比
财年依据，价格截至各公司上一个财年末收盘价。
| 股票代码 | 市值 | P/E | 营收同比增长 | 净利润率 | ROE | 毛利率 |
|---|---|---|---|---|---|---|
| KOD | $1.73B | -6.5 | · | · | -202.0% | · |
| RYTM | $7.19B | -34.4 | 45.8% | -103.6% | -309.1% | · |
| IOVA | $1.12B | -2.5 | 60.6% | -148.4% | -56.0% | · |
| GRAL | $3.45B | -7.7 | 17.2% | -277.5% | -16.7% | · |
| CGON | $3.35B | -20.0 | 254.7% | -3985.0% | -22.6% | · |
| SRRK | $4.78B | -13.4 | · | · | -157.9% | · |
| ORKA | $1.48B | -3.3 | · | · | -25.9% | · |
| COGT | $5.72B | -16.4 | · | · | -83.1% | · |
| TVTX | $3.47B | -131.8 | 110.5% | -5.2% | -34.6% | · |
| MIRM | $4.10B | -168.1 | 54.7% | -4.5% | -8.2% | · |
| PTCT | $6.19B | 9.8 | 114.5% | 39.4% | -331.5% | · |
最新新闻 提及该公司的近期头条新闻
我的指标 您的个人关注列表 — 来自完整基本面的选定行
选择对您重要的指标 — 点击上方完整基本面中任意行的 + 号。
您的选择已保存，并会跟随您浏览所有股票。
来源：SEC 10-Q 于 八月 13, 2026 申报